EUVIMEDEUVIMED entdecken
Crossref

REGULATORY AND INNOVATION HISTORY IN WEIGHT-LOSS GENERICS

INDIAN DRUGS · 28.03.2026 · 63 (03) · 5-7

DOI: 10.53879/id.63.03.p0005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift INDIAN DRUGS, online erschienen am 02.04.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dear Reader, The year, 2026 and the month of March, 2026 is remarkably going down in history for multiple reasons and events. Oil and gas have taken the global news by storm with the war at Iran and gulf, while March 2026 has become most relevant for pharma industry, regulators and innovators for the flood-gates getting opened for weight-loss generics. The evolution of anti-obesity drugs has also highlighted the importance of pharmacovigilance as never before.

Zitieren

APA

(2026). REGULATORY AND INNOVATION HISTORY IN WEIGHT-LOSS GENERICS. INDIAN DRUGS, 63(03), 5-7. https://doi.org/10.53879/id.63.03.p0005

Vancouver

REGULATORY AND INNOVATION HISTORY IN WEIGHT-LOSS GENERICS. INDIAN DRUGS. 2026;63(03):5-7. doi:10.53879/id.63.03.p0005

BibTeX
@article{euvimed2026,
  title = {REGULATORY AND INNOVATION HISTORY IN WEIGHT-LOSS GENERICS},
  journal = {INDIAN DRUGS},
  year = {2026},
  volume = {63},
  number = {03},
  pages = {5--7},
  doi = {10.53879/id.63.03.p0005}
}
Kostenlos starten →